Molecular Recognition in Purinergic Receptors. 1. A Comprehensive Computational Study of the h-P2Y1-Receptor
- 1 August 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (18) , 4391-4404
- https://doi.org/10.1021/jm049772m
Abstract
P2Y receptors (P2Y-Rs) are attractive pharmaceutical targets due to their involvement in the modulation of many tissues and organs. The lack of experimental structural data on P2Y-Rs impedes structure-based drug design. The need to elucidate the receptor's molecular recognition, together with the limitations of previous receptor models, triggered the construction of a new molecular model for the h-P2Y1-R. Therefore, a h-P2Y1-R model was constructed by homology modeling using the 2.6 Å crystal structure of bovine rhodopsin as a template and subsequently refined by constrained molecular dynamics (MD) simulations in a fully hydrated lipid bilayer environment. ATP was docked into the receptor binding site, followed by binding site refinement using Monte Carlo and MD simulations. Analysis of the h-P2Y1-R−ATP complex suggests that the triphosphate moiety is tightly bound by a multitude of interactions possibly including a Mg2+ ion, the ribose ring is not involved in specific interactions, and the adenine ring is bound via N1, N7, and N6. The molecular recognition of the h-P2Y1-R was further probed by ATP derivatives modified on the adenine ring, and correlated with EC50 values for these derivatives. Analysis of receptor:ligand complexes and quantum mechanical studies on model compounds support the role of both steric and electronic effects in improving H-bonding (via N1 and N6) and π-stacking interactions. The computed h-P2Y1-R model was validated with respect to our previous biochemical results. We believe that this new model of the h-P2Y1-R provides the means for understanding phenomena such as the ligand's potency and receptor subtype selectivity.Keywords
This publication has 43 references indexed in Scilit:
- Purine and Pyrimidine (P2) Receptors as Drug TargetsJournal of Medicinal Chemistry, 2002
- Novel modified adenosine 5′-triphosphate analogues pharmacologically characterized in human embryonic kidney 293 cells highly expressing rat brain P2Y1 receptor:: Biotinylated analogue potentially suitable for specific P2Y1 receptor isolationBiochemical Pharmacology, 2001
- Pharmacological evaluation and chemical stability of 2-benzylthioether-5′-O-(1-thiotriphosphate)-adenosine, a new insulin secretagogue acting through P2Y receptorsDrug Development Research, 2001
- Advances in signalling by extracellular nucleotidesCellular Signalling, 2000
- Purinergic and pyrimidinergic receptors as potential drug targetsBiochemical Pharmacology, 2000
- Therapeutic applications of ATP-(P2)-receptors agonists and antagonistsExpert Opinion on Therapeutic Patents, 1999
- THE FUNCTIONS OF ATP RECEPTORS IN THE HIPPOCAMPUSPharmacological Research, 1998
- The regulation of vascular function by P2 receptors: multiple sites and multiple receptorsTrends in Pharmacological Sciences, 1998
- Nucleotide receptors in the nervous systemMolecular Neurobiology, 1997
- P2 purine and pyrimidine receptors: emerging superfamilies of G-protein-coupled and ligand-gated ion channel receptorsEuropean Journal of Medicinal Chemistry, 1997